{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-003715","form_type":"8-K","ticker":"DRMA","cik":"0001853816","company_name":"Dermata Therapeutics, Inc.","filed_at":"2026-01-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.545897+00:00","generated_at":"2026-05-16T07:36:30.375689+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Dermata increases ATM offering capacity by $705K; previously sold $3.45M under same program","bullets":["Filed prospectus supplement to increase maximum aggregate offering under ATM by $705,000.","Prior sales under the June 2024 H.C. Wainwright ATM agreement totaled $3,454,390.","ATM program covers common stock issuances; legal opinion filed as Exhibit 5.1.","No change in business fundamentals; routine capital access expansion."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-003715","json":"https://secwatch.observer/filing/0001493152-26-003715.json","markdown":"https://secwatch.observer/filing/0001493152-26-003715.md","text":"https://secwatch.observer/filing/0001493152-26-003715.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226003715/0001493152-26-003715-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226003715/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T07:36:30.375689+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}